CLOs on the Move

Cyrano Therapeutics

www.cyranotherapeutics.com

 
The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Applied Laboratories

Applied Laboratories, Inc. is dedicated to providing quality customer services and specializes in meeting client needs and timelines based on its streamlined organizational structure and experienced and knowledgeable staff. We attract our customers with

HydraFacial

BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Our flagship brand, Hydrafacial, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator, Hydrafacial uses a unique delivery system to cleanse, extract, and hydrate with their patented hydradermabrasion technology and super serums that are made with nourishing ingredients, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. Hydrafacial® and Perk™ products are available in over 87 countries with over 19,000 Delivery Systems globally and millions of treatments performed each year. Hydrafacial is a wholly owned subsidiary of BeautyHealth. BeautyHealth`s shares trade on the Nasdaq Capital Market under the ticker symbol SKIN.

Bilcare Research

Bilcare Research is a Delaware City, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.  

Orthovita

Orthovita, Inc. is a Malvern, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.